1. Companies

  2. Greenbrook

Greenbrook

Greenbrook

TMS Therapy for Depression | Depression Treatment | Greenbrook TMS. Learn more
Launch date
Employees
201-500 people
Market cap
AUD3.2m
Enterprise valuation
AUD167m (Public information from Feb 2024)
Tysons Virginia (HQ)
https://www.greenbrooktms.com/
https://twitter.com/greenbrooktmshttp://www.linkedin.com/company/tms-neurohealth-centers
View job openings

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2018201920202021202220232024
Revenues21.3m35.7m43.1m52.2m69.1m73.8m89.4m
% growth54 %68 %21 %21 %32 %7 %21 %
EBITDA(4.6m)(6.6m)(11.1m)(16.4m)(19.2m)(28.8m)2.0m
% EBITDA margin(21 %)(18 %)(26 %)(31 %)(28 %)(39 %)2 %
Profit(5.0m)(15.9m)(29.7m)(24.8m)(61.7m)(48.9m)-
% profit margin(23 %)(45 %)(69 %)(47 %)(89 %)(66 %)-
EV / revenue3.3x2.7x3.6x2.1x2.3x1.9x0.1x
EV / EBITDA-15.6x-14.7x-14.1x-6.7x-8.2x-4.8x6.3x
R&D budget<1m1.5m<1m<1m<1m--
R&D % of revenue2 %4 %1 %2 %1 %--
    • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

CAD17.0m

IPO
N/A

$11.5m

Post IPO Equity
*
N/A

$75.0m

Post IPO Debt
*

$2.0m

Post IPO Debt
*
N/A

$750k

Post IPO Convertible
*
N/A

$6.3m

Private Placement VC
*

$1.5m

Post IPO Debt
*

$2.0m

Post IPO Debt
*

$2.5m

Post IPO Debt
*

$5.3m

Post IPO Debt
*

$1.5m

Post IPO Debt
*

N/A

Acquisition
Total FundingAUD9.7m

Recent News about Greenbrook

Edit
More about Greenbrook
Edit

Greenbrook TMS NeuroHealth is the nation’s leading provider of Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and Obsessive Compulsive Disorder. Since 2011, we’ve provided more than 320,000 life-changing TMS treatments to over 9,000 patients. Learn more at greenbrooktms.com

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Greenbrook

Edit
Achieve TMS East and Central
Achieve TMS East and Central
ACQUISITION by Greenbrook Sep 2021
Success TMS
Success TMS
ACQUISITION by Greenbrook May 2022